Michael G. Strainic
5Patents
2h-index
5Co-inventors
40Inventor score
Filing activity: Mar 2, 2009 → Apr 10, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8940299B2 | Method of treating cancer | Chemistry; Metallurgy | 10 | Active |
| US11130801B2 | Method for inhibiting platelet derived growth factor signaling with C3aR or C5aR antibodies | Physics | 6 | Active |
| US9290736B2 | Compositions and methods of treating T cell mediated disorder | Chemistry; Metallurgy | 2 | Active |
| US10933093B2 | Compositions and methods of treating a T cell mediated disorder | Chemistry; Metallurgy | 0 | Active |
| US9937206B2 | Compositions and methods of treating T cell mediated disorder | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.